Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06307522 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MRG-001 in Patients With Alcoholic Hepatitis

StatusNot Yet Recruiting
PhasePhase 2
Started2024-09-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 13, 2024 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.
The goal of this study is to test MRG-001 (an experimental medication). The purpose of this trial is to assess the dose related safety, Pharmacokinetics, and Pharmacodynamics of MRG-001 in patients with severe alcoholic hepatitis (AH).
Trial Details
NCT Number NCT06307522
Lead Sponsor MedRegen LLC
Conditions Alcoholic Hepatitis, Acute Alcoholic Hepatitis
Enrollment 32 participants
Start Date 2024-09-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-03-13